r-connect supported the Interdisciplinary Platform on Benefit Assessment
European HTA Procedure: endpoints count? Advances and Pitfalls
Where to find us

r-connect is based in Basel (Switzerland), the home of some of the largest pharmeceutical companies in the world.

Our address is: r-connect GmbH
Hauensteinstr. 132
4059 Basel
Switzerland



Who we are

Jörg Ruof, PhD
Founder r-connect
Besides my enthusiasm for Market Access and Medical topics, beekeeping has always helped me to r-e-connect to the bare essentials. Bees have a fascinating approach to successful collective decision-making and produce some exceptionally healthy products. This is exactly what a health system should aim to do: optimize collective decision-making and ensure that healthy products are reaching patients.

Jörg Ruof has a solid educational and academic background (MBA, Edinburgh Business School and Professor of Medicine, Hanover Medical School) and a huge amount of work experience in various clinical, academic, and industrial environments. Key milestones in his career are:
  • MD, PhD at the University of Witten/Herdecke, Germany
  • Practical training in internal medicine and rheumatology at the Hanover Medical School
  • The design and conduct of the Hanover Costing Study, an analysis of a major set of real world health services data
  • Development, transcultural adaptation, and methodological validation of various instruments to capture Patient Reported Outcomes
  • Presentation of health economic and regulatory data sets to the US Federal Drug Administration and to international health authorities in the United Kingdom, Norway, Sweden, etc.
  • Leading an HIV sales team in the 5 Boroughs of New York
  • Leading the Franchise for novel biologic treatments in Rheumatoid Arthritis and introducing RoActemra into the German Market
  • Leading the Market Access / HTA Team of Roche Germany between 2011 - 2016



Sonja Merkesdal
Associate r-connect
In 2019, Sonja Merkesdal joined r-connect. Sonja’s vast experience in medical writing, her in depth knowledge of methodological and statistical approaches and her passion for patient centric Health Technology Assessment are an ideal fit with r-connect's aims and focus.

  • MD, PhD at Hanover Medical School
  • Diploma in Economic Sciences University of Hagen
  • Internship Internal Medicine, Hanover Medical School, Germany
  • Associate Professor for Health Economics at Hanover Medical School
  • Author of ~50 peer-reviewed scientific publications on Health Economics / Health Outcomes / Public Health subjects



Charles Piwko
President CHP Pharma
To run global projects, r-connect, Basel, Switzerland and CHP Pharma, Toronto, Canada have ventured into a strategic partnership.

Charles Piwko holds a Pharmacy Doctor degree, a PhD in Pharmacology, and a MSc in Health Administration. He performed his Master Thesis at the University of Toronto and the Hospital for Sick Children in Toronto from 2002-2005 and was previously Manager of Pharmacy 12 in Zurich, Switzerland from 1996-2001. From 1994-1996 he held a position in the Department of Preclinical CNS-Pharmacology at Novartis Pharma AG in Basel.